Organization · Venture Studio
Nuqleus
Nuqleus is a deep-tech venture builder and startup program based in Croatia, focused on commercializing scientific research through innovative technology solutions.
Overview
What Nuqleus does
What Nuqleus is
Nuqleus is a deep-tech venture builder and startup program based in Croatia, focused on commercializing scientific research through innovative technology solutions.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 2, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Nuqleus elsewhere
Open the official website or a supported primary organization account.
Capability profile
Nuqleus as a funder
Investment thesis
Nuqleus aims to strengthen applied research and support the commercialization of scientific research results through its Startup Builder program, focusing on deep-tech innovations.
Focus narrative
Nuqleus focuses on the commercialization of scientific research results through its Startup Builder program. This program is structured in three phases, aiming to identify significant societal and industrial challenges, propose innovative technological solutions, and form interdisciplinary teams to develop these solutions. The organization supports startups in various sectors, particularly in deep-tech, and emphasizes collaboration between scientific research institutions and industry.
Value beyond capital
Nuqleus provides mentorship, resources, and strategic guidance to startups through its structured programs, fostering collaboration between scientific research and industry to drive innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 23
Portfolio context
Nuqleus has incubated 23 startups and established 16 spin-off companies, collectively securing over €1.8 million in investments. Notable startups include EMHANCE, which developed a non-invasive device for personalized treatment of brain diseases; P3 Therapeutics, a preclinical biotech company focused on developing small chemical molecules for treating chronic inflammation; and eDNAture, which utilizes environmental DNA technology for rapid detection of biological threats.
Capability profile
Nuqleus as a program host
Program thesis
Nuqleus is a deep-tech venture builder focused on commercializing scientific research results and supporting startups through its Startup Builder program.
Focus narrative
Nuqleus focuses on the commercialization of scientific research results through its Startup Builder program. This program is structured in three phases, aiming to identify significant societal and industrial challenges, propose innovative technological solutions, and form interdisciplinary teams to develop these solutions. The organization supports startups in various sectors, particularly in deep-tech, and emphasizes collaboration between scientific research institutions and industry.
Value and support
Nuqleus offers mentorship, resources, and strategic guidance through its Startup Builder program, helping startups develop innovative solutions and navigate the market.
Additional public guidance
Q: What is the Startup Builder program? A: It is a structured program designed to support startups in developing solutions to societal and industrial challenges. Q: When do applications open? A: Applications open annually from October 1st to November 7th.
Terms and economics
- Indicative investment
- $1,800,000
Availability
- Application state
- Accepting
- Next deadline
- November 7, 2023
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Europe
Alumni and track record
Alumni context
Nuqleus has incubated 23 startups and established 16 spin-off companies, collectively securing over €1.8 million in investments. Notable startups include EMHANCE, which developed a non-invasive device for personalized treatment of brain diseases; P3 Therapeutics, a preclinical biotech company focused on treating chronic inflammation; and eDNAture, which utilizes environmental DNA technology for rapid detection of biological threats.
Common questions
What to know about Nuqleus
Upseed classifies Nuqleus under the Venture Studio organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 2, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.